Actavis Spain Chooses Data3s, Implements eluzzion CRM for its Sales Force

March 18, 2011 - PRLog -- European pharmaceutical CRM leader Data3s announced today that the Actavis Group has chosen to implement eluzzion CRM to support its Spanish sales force.

The Actavis Group's Spanish affiliate, Actavis Spain SA, was incorporated at the end of 2007, and started operations in July 2008. The Company is currently marketing generics retail products, branded, oncology hospital and over-the-counter (OTC) products in the Spanish market. Data3s is one of the fastest growing providers of CRM and BI solutions for the life sciences industry.

Describing the decision in favor of Data3s, Actavis' Director Sales Force Effectiveness Europe, Stefan Langthaler, said, "For me the system itself, as well as fancy power point slides, can never give a comparable impression to what you feel in a discussion when professionals from our generic business are sitting across from us. And this is the most important lesson for me from our meetings with Data3s."

"It made a big difference to us that Data3s was a company that originated inside pharma," Langthaler added. "They built the foundation for eluzzion CRM while they were still at Zentiva [now part of the Sanofi-aventis Group] and it very quickly became clear that their background gave them a deep understanding of the pharma business and the needs of generics companies like Actavis."

eluzzion CRM, Data3s' key solution for life science companies, is an all-in-one business solution for pharmaceutical sales and marketing, with key support for Financial, HR, R&D and Distribution decision-makers.

Based on Microsoft’s .NET 4.0 technology framework, eluzzion’s 20+ integrated modules are complemented by robust Administration and Reporting tools that empower companies to independently manage and optimize their operations with the support of powerful analytic and diagnostic tools with a feature-rich, easy-to-use interface and 100% data flexibility.

According to Cristian Burrows, Data3s' Sales Director, "Among the most important functions for Actavis Spain are eluzzion's built-in BI Tools, OLAP cubes and eluzzion's personalized analytic Home Page dashboards, as well as eluzzion's Transfer Orders module, which allows our client to connect their order processes directly to their back office, and Admin Tools,  which allow them to configure ad hoc every aspect of their sales campaigns."

"We are very pleased that eluzzion CRM's built-in functions are able to support Actavis Spain's complex processes," Burrows added, "and we will work hard to deliver the solution they need."

For more news, please visit: http://data3s.com/

About Actavis:

The Actavis Group is one of the world’s leading players in the development, manufacture and sale of high-quality generic pharmaceuticals. The successful integration of a number of acquisitions has helped position Actavis among the world’s largest companies in the industry. Founded in 1956, the Group has more than 10,000 employees operating in about 40 countries around the globe. The Actavis Group's Spanish affiliate, Actavis Spain SA, was incorporated at the end of 2007, and started operations in July 2008.

# # #

About Data3s:

Data3s is one of the fastest growing providers of CRM and BI solutions for the life sciences industry. Our key product is eluzzion CRM, an innovative front-to-back-office platform for pharmaceutical companies that packs powerful analytics inside one of the most user-friendly interfaces in Pharma. Our pharma support services include pharmaceutical Sales Force Effectiveness (SFE) planning and implementation, KPI scoring, business analytics, reporting services, as well as a full range of pharmaceutical back office solutions, from budgeting to document and data management. Our customers include leading life sciences companies who depend on Data3s to support their SFE goals with flexible and adaptive technologies that keep them ahead of the curve.

Learn more by visiting us at http://data3s.com/pharma-crm